Using iodine as catalyst to advance the sustainability of pharmaceutical syntheses Synthesizing pharmaceuticals for cancer, viral diseases, and other medical conditions is slow work. A particularly challenging chemical transformation is to start with what's known as an unactivated alkene--a common molecular building block--and end up with a vicinal diamine; i.e., installation of two nitrogen units into carbon--carbon double bonds. The result is a chemical unit that's present in medications for influenza and colorectal cancer. Commonly, researchers must use rare, toxic metals and harsh reactio...